A Spatio-Temporal Analysis of Matrix Protein and Nucleocapsid Trafficking during Vesicular Stomatitis Virus Uncoating by Mire, Chad E. et al.
A Spatio-Temporal Analysis of Matrix Protein and
Nucleocapsid Trafficking during Vesicular Stomatitis
Virus Uncoating
Chad E. Mire
1¤, Judith M. White
2, Michael A. Whitt
1*
1Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America, 2Department of Cell Biology,
University of Virginia, Charlottesville, Virginia, United States of America
Abstract
To study VSV entry and the fate of incoming matrix (M) protein during virus uncoating we used recombinant viruses
encoding M proteins with a C-terminal tetracysteine tag that could be fluorescently labeled using biarsenical (Lumio)
compounds. We found that uncoating occurs early in the endocytic pathway and is inhibited by expression of dominant-
negative (DN) Rab5, but is not inhibited by DN-Rab7 or DN-Rab11. Uncoating, as defined by the separation of nucleocapsids
from M protein, occurred between 15 and 20 minutes post-entry and did not require microtubules or an intact actin
cytoskeleton. Unexpectedly, the bulk of M protein remained associated with endosomal membranes after uncoating and
was eventually trafficked to recycling endosomes. Another small, but significant fraction of M distributed to nuclear pore
complexes, which was also not dependent on microtubules or polymerized actin. Quantification of fluorescence from high-
resolution confocal micrographs indicated that after membrane fusion, M protein diffuses across the endosomal membrane
with a concomitant increase in fluorescence from the Lumio label which occurred soon after the release of RNPs into the
cytoplasm. These data support a new model for VSV uncoating in which RNPs are released from M which remains bound to
the endosomal membrane rather than the dissociation of M protein from RNPs after release of the complex into the
cytoplasm following membrane fusion.
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Introduction
The entry of enveloped viruses that utilize the clathrin-
dependent endocytic pathway involves attachment of virus to the
cell surface and uptake of virions in coated vesicles that are
transported to early or late endosomes. When virions reach a
compartment in which the lumen has the appropriate pH there is
an acid-induced fusion of the endosomal and viral membranes
which results in virus uncoating and release of the genome into
the cytoplasm [1,2]. Vesicular stomatitis virus (VSV), a prototypic
enveloped, nonsegmented, negative-strand RNA virus in the
Rhabdoviridae family enters host cells through the clathrin- and pH-
dependent endocytic pathway [3,4,5,6]. The genome of VSV
encodes five major viral proteins: the nucleocapsid protein (N), the
phosphoprotein (P), the matrix protein (M), the glycoprotein (G),
and the large polymerase protein (L). The viral genome is
encapsidated by the N protein and associates with the viral RNA-
dependent RNA polymerase (RdRp), which consists of a complex
of the L and P proteins. The N-RNA-RdRp collectively forms the
ribonucleoprotein (RNP) complex. The M protein within virions is
associated with RNPs in structures called skeletons [7,8]. Recently,
cryo-EM imaging of intact VSV particles showed that the RNP
skeleton consists of a compact left-handed helix bounded by an
outer layer of M protein which anchors the RNP to the viral
membrane [9]. Protruding from the virion surface are glycopro-
tein spikes consisting of G protein trimers. G protein is responsible
for attachment of virions to cells and fusion of the endosomal and
viral membranes, which results in the transfer of the RNP into the
cytoplasm where VSV replication occurs [3]. Early models of VSV
uncoating proposed that either directly after or concomitant with
membrane fusion, M protein dissociates from RNPs, which results
in decondensation of the skeleton [7,8] and completes virus
uncoating [10]. More recently, it was proposed that VSV initially
fuses with vesicles found within multivesicular bodies and that the
release of nucleocapsids into the cytoplasm occurs after transport
to late endosomes, which requires a back-fusion event [11], and
that Tsg101 controls the endosome-to-cytosol release of nucleo-
capsids [12]. After uncoating, the decondensed RNP serves as a
template for transcription of viral mRNAs by the packaged RNA-
dependent RNA polymerase.
VSV uncoating, defined as the dissociation of M from RNPs, is
an essential step which is required for a productive infection [13].
Without uncoating it is thought that transcription of viral mRNAs
will not occur since it has been shown that transcription from
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also shared by another enveloped negative-strand virus, influenza
virus, which requires the release of its matrix protein (M1) for
a productive infection [17,18]. To better understand the
requirements for VSV uncoating, we generated recombinant
VSV (rVSV) which encoded M proteins that had tetracysteine
(-CCRECC-) Lumio tags at either the N- or C-terminus, and
recovered infectious virus [19]. Similar rVSVs have been
described by others [20] and have been used to study VSV entry
and assembly. Previously, using rVSV containing M protein
labeled with Lumio Green (rVSV-MLG), we found that during
entry the interior of VSV virions become acidified and that
acidification required G protein [19]. Furthermore, we obtained
evidence that virion acidification enhanced M protein release and
proposed a model in which G protein-induced acidification
facilitates VSV uncoating by causing subtle conformational
changes in M protein which results in the dissociation of M from
RNPs.
In this report we examine the kinetics of VSV uncoating and the
fate of virion-associated M protein and RNPs during VSV entry
and after uncoating using rVSV-MLG. We show that after fusion
of the viral membrane with endosomes, the bulk of M protein
remained associated with vesicular structures and eventually
colocalized with markers for recycling endosomes. Although most
of M remained bound to endosomal membranes, a small, but
significant fraction of M protein was released and localized to the
nuclear envelope. The delivery of M protein to the nuclear
envelope was not dependent on microtubules or an intact actin
cytoskeleton. Using confocal microscopy we observed that RNPs
entered the cytoplasm and physically separated from M protein
between 15 and 20 minutes post-entry and that the release of
RNPs into the cytoplasm was also not dependent on microtubules
or intact microfilaments. Following RNP release, the membrane-
bound M protein diffuses across the endosomal membrane with a
concomitant increase in MLG fluorescence. Collectively, these
data provide strong evidence that VSV uncoating involves the
direct release of RNPs from membrane-associated M protein into
the cytoplasm where viral transcription can take place to initiate a
productive infection.
Results
Productive infection requires Rab5, but not Rab7 or
Rab11
Recently, using rVSV containing Lumio-Green labeled M
protein (rVSV-MLG), we reported that very soon after endocytosis
the interior of VSV virions become acidified resulting in a
decrease in input MLG fluorescence [19]. This is followed by a
recovery of fluorescence to the original input levels at approxi-
mately 10 minutes post-entry, which we proposed is due to
exposure of MLG to the neutral pH of the cytoplasm and
therefore is a marker for VSV membrane fusion and the initiation
of virus uncoating [19]. These results are consistent with models in
which the release of VSV RNPs occurs from early endosomes.
To further define the intracellular location of VSV uncoating
we examined the effect of dominant-negative (DN) Rab proteins
on rVSV-wt infection. Rab5, 7 and 11 are GTPases that are
required for the movement of endocytosed cargo to early (Rab5),
late (Rab7), or recycling (Rab11) endosomes [21,22,23]. Expres-
sion of DN-Rab5 prevents fusion of endocytic vesicles with early
endosomes, while DN-Rab7 and 11 prevent movement from early
to late, or to recycling endosomes, respectively. BHK-21 cells were
transfected with plasmids encoding eGFP-tagged DN-Rabs and
then the cells were infected with rVSV-wt 18 h post-transfection.
The cells were fixed 8 hours later, permeabilized, and stained for
VSV nucleocapsid (N) protein using an N-specific monoclonal
antibody (mAb-10G4; [24]) conjugated to Alexa Fluor-568. As
shown in Fig. 1, most cells expressing DN-Rab7 and DN-Rab11
were infected, but cells expressing DN-Rab5 were not and
infection was inhibited by ,70%. Expression of the wt-Rab
proteins had only minimal effects on VSV infection (Fig. 1B).
These data support previous reports which showed VSV could
infect cells expressing DN-Rab7, but not cells expressing DN-
Rab5 [4,5]. Inhibition of VSV infection by DN-Rab5 was highly
significant (p=0.002), but the small inhibition observed with DN-
Rab11 was not (p=0.1549). To ensure our DN-Rab7 construct
was functional we examined the effect of the DN-Rabs on
influenza A virus infection. As shown previously [5], DN-Rab5
and 7 inhibited influenza virus infection (Fig. 1B), while DN-
Rab11 did not. Collectively, these data indicate that the majority
of VSV virions fuse and uncoat after delivery to early endosomes
and that VSV infection does not require transfer to late
endosomes.
Live-cell entry of rVSV-MLG
To study VSV uncoating and the fate of incoming M protein,
rVSV-MLG and transferrin-Texas Red (Tfn-TR) were adsorbed
to cells for 90 minutes at 4uC to prevent endocytosis and then
entry was initiated by replacing the inoculum with media pre-
warmed to 37uC. The Tfn-TR was used as a surface (t-0) and
endosomal (post t-0) marker for most of the studies described
below. To differentiate surface-bound from endocytosed Tfn-TR,
the cells were treated with acidic buffer containing an iron
chelating agent, which removes transferrin bound to transferrin
receptor on the cell surface. Acid washing (AW) of cells prior to the
addition of warm media and the initiation of endocytosis resulted
in the loss of the Tfn-TR signal (Fig. 2, t-0 AW), but had no effect
on bound virus. Five minutes after transferring the cells to 37uC
virtually all of the Tfn-TR was endocytosed (Fig. 2, t-5 AW). Based
on colocalization of Tfn-TR and MLG fluorescence, the vast
majority of rVSV-MLG was also endocytosed, which is consistent
with two recent reports showing that VSV is rapidly internalized
[4,6]. Because of concerns that acid treatment may induce
Author Summary
Vesicular stomatitis virus (VSV) is a prototypic enveloped
virus that enters cells following endocytosis and a low pH-
dependent membrane fusion event between the viral and
endosomal membrane. To initiate a productive infection
the viral nucleocapsid must dissociate from the matrix (M)
protein, which underlies the viral membrane, in a process
known as uncoating. The requirements for VSV uncoating
are poorly understood. Here we used a virus containing
fluorescent M protein to follow VSV uncoating in live cells.
This analysis resulted in three new findings which provide
for the first time a description of matrix and nucleocapsid
trafficking during VSV uncoating. We found that most of
the M protein remains bound to the endosomal mem-
brane after virus-endosome fusion and that the nucleo-
capsid is released into the cytoplasm where replication
occurs. While most of M remains membrane-bound, a
small but detectable fraction is released during uncoating
and is trafficked to nuclear pores. This has not been
previously observed and may aid in shutting down host
responses to infection. Collectively we provide the first
spatio-temporal description of VSV uncoating by visualiz-
ing the uncoating process in live cells.
VSV Entry and Uncoating
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studies were performed without an acid wash step.
The bulk of M protein remains associated with
transferrin-positive endosomes
To examine the kinetics of virus entry and to follow the
trafficking of M protein, rVSV-MLG and Tfn-TR were bound to
cells in the cold as described in Fig. 2, and after the addition of
warm media the cells were incubated for the specified times and
examined by laser scanning confocal microscopy (LSCM; Fig. 3).
At t-0, rVSV-MLG and Tfn-TR decorated the cell surface and
showed some colocalization. After 5 min (not shown) both markers
were internalized and most of the rVSV-MLG virions were in
transferrin-positive endosomes. Between 10 to 30 minutes,
endosomes containing Tfn-TR and MLG moved from the cell
periphery towards the cell interior. Notably, the bulk of MLG
remained associated with Tfn-TR-positive endosomes until the last
time point examined (t-150).
Delivery of M to the nuclear envelope
In addition to the endosomal-associated fraction a small amount
of MLG began to accumulate on what appeared to be the nuclear
envelope beginning 20 minutes post entry (Fig. 3, arrowheads).
Association of MLG with this structure continued to increase up to
the last time point examined. At no time did we observe Tfn-TR
associated with the nuclear envelope suggesting this was not due to
membrane recycling to the endoplasmic reticulum surrounding
the nucleus.
To determine if trafficking of MLG to the nuclear envelope
required membrane fusion and virus uncoating rVSV-MLG and
Tfn-TR were bound to cells that had been pretreated with
bafilomycin A1, which inhibits endosome acidification and
prevents VSV infection, and examined by LSCM at various times
as described for Fig. 3. At no time did we observe MLG
associating with the nuclear envelope in cells treated with
bafilomycin A1 (Fig. 4A). To determine if ongoing protein
synthesis was required we synchronized fusion of the viral and
endosomal membrane using ammonium chloride in the presence
of cycloheximide. Ammonium chloride (NH4Cl) is a lysosomo-
tropic agent that prevents acidification of endosomes and thereby
inhibits fusion and uncoating of endocytosed virions [10,25], but
unlike bafilomycin A1, NH4Cl can be easily washed out of cells
allowing rapid re-acidification of endocytic compartments. Fol-
lowing entry in the presence of NH4Cl, the inoculum and NH4Cl
were removed, the cells were washed 4 times, and media
containing cycloheximide was added. Cells were fixed either
immediately or 60 minutes after NH4Cl removal. The cells were
then permeabilized and stained with anti-Nup62 antibody, which
binds to the nuclear pore complex (NPC) on the nuclear envelope,
and with an anti-M mAb (23H12; [24]) and examined by LSCM
(Fig. 4B). At t-0, rVSV-MLG particles were in small vesicular
structures (endosomes) and no M protein was detected at the
nuclear envelope (Fig. 4B, top panels). Similar to the results shown
in Fig. 3, at t-60 the bulk of MLG was found in large, mostly
perinuclear endosomes and a small but significant amount of
MLG was localized to the nuclear envelope (Fig. 4B, t-60 arrows).
These data indicate that while most of the incoming (e.g. virion-
associated) M protein remains associated with Tfn-positive
endosomes, a small amount of M trafficks to the NPC after
uncoating. As reported by others, the M mAb (23H12) did not
detect M protein bound to nuclear envelope (Fig. 4B, yellow
arrows), which explains why earlier studies examining VSV
uncoating [10] did not observe delivery of M protein to the NPC.
The epitope recognized by the 23H12 M mAb overlaps the region
of M that binds to the nuclear shuttling protein RaeI [26,27],
suggesting that the fraction of MLG which associates with the
nuclear envelope is likely complexed with RaeI.
Trafficking of MLG in the presence of cytoskeletal
inhibitors
To determine if microtubules or microfilaments are required for
the delivery of MLG to the nuclear envelope cells were inoculated
with rVSV-MLG in the presence of NH4Cl for 60 minutes and
then the cytoskeletal inhibitors cytochalasin D or nocodazole were
added for 30 minutes. The NH4Cl was removed by washing the
cells with media containing cycloheximide either with or without
cytoskeletal inhibitors and incubated for an additional 60 minutes.
The cells were then fixed and stained for filamentous actin using
Figure 1. Effect of DN-Rab expression on VSV infection. Cells
were transfected with plasmids expressing DN- or wt-Rab-eGFP
proteins and infected with rVSV-wt or influenza virus at 18 hours
post-transfection. Cells were fixed, permeabilized and stained for VSV N
protein or influenza NP at 8 hr post-infection. (A) Fluorescence and
brightfield micrographs showing the effect of DN-Rab5 (top panels),
DN-Rab7 (middle panels), and DN-Rab11 (bottom panels) on VSV
infection. Arrows mark cells expressing Rab-eGFP proteins. (B) Inhibition
of virus infection was quantified by determining the number of Rab-
positive cells that were also infected by VSV or influenza virus. Statistical
significance for effect on VSV infection was determined using Student’s
t-test (*= p , 0.002) from 152 cells (Rab5), 153 cells (Rab7), or 156 cells
(Rab11).
doi:10.1371/journal.ppat.1000994.g001
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the absence (top panels) or presence of the inhibitors (bottom
panels), MLG was found in association with endosomes and at the
nuclear envelope (arrows). These results indicate that delivery of
MLG to the nuclear envelope does not require an intact actin
cytoskeleton or microtubules.
Colocalization of MLG and markers of recycling
endosomes
The images in Fig. 3 show that the bulk of MLG remains
associated with Tfn-positive endosomes for at least 150 min after
entry. To determine the identity of these perinuclear structures we
used markers that corresponded to lysosomes (LAMP-1), late
endosomes/lysosomes (Mannose-6-Phosphate receptor, M-6-P-R),
or recycling endosomes (Tfn-TR and Rab11). rVSV-MLG was
endocytosed in the presence of NH4Cl as described for Fig. 4, the
inoculum and NH4Cl were removed and the cells were incubated
for an additional 60 min and then stained using antibodies to the
various endosomal markers, or visualized directly for Tfn-TR.
Quantification of MLG colocalization with the various markers
indicated that most of incoming M protein remains associated with
membranes that mature into recycling endosomes (Fig. 6C and D),
while only some MLG is delivered to late endosomes (Fig. 6B) and
lysosomes (Fig. 6A).
Separation of RNPs from MLG correlates with productive
infection and does not require microtubules
It is not known if VSV RNPs are released into the cytoplasm, or
if they remain associated with membranes after uncoating in vivo.
To further define the site of virus uncoating we asked whether we
could detect nucleocapsids physically separating from MLG after
endocytosis. Cells were inoculated with rVSV-MLG as described
in Fig. 3, except that Tfn-TR was not included, and entry was
initiated after transfer to 37uC. Cells were fixed and RNPs were
detected by staining for N protein at the times indicated. At t-5,
the majority of RNPs colocalized with MLG (Fig. 7A and C).
Beginning approximately 10 minutes post-entry RNPs could be
seen separating from MLG-endosomes. The largest change in
RNP-MLG colocalization occurred between 15 and 20 minutes;
quantification of the fraction of RNPs that colocalized with MLG
Figure 2. Endocytosis of surface bound Tfn-TR and rVSV-MLG. rVSV-MLG and Tfn-TR were bound to cells at 4uC for 90 minutes and the cells
were either (top panels) fixed immediately with ice-cold 3% paraformaldehyde (t-0), or (middle panels) treated with acidic desferrioxamine to strip
Tfn-TR from the cell surface (t-0, AW) and then fixed, or (bottom panels) warmed by replacing the inoculum with 37uC media for 2 minutes followed
by quickly cooling with the addition of ice-cold PBS, and then acid-desferrioxamine washed on ice. After the acid wash the cells were warmed to
37uC, the cells were incubated for an additional 3 minutes (t-5, AW) and then examined without fixation by LSCM on a heated stage. Bars = 5 mm.
DIC = differential interference contrast.
doi:10.1371/journal.ppat.1000994.g002
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50% at t-20 (Fig. 7B). We also examined RNP-M separation
biochemically using a cell fractionation protocol to determine if
the results seen by fluorescence confocal microscopy could be
reproduced by an independent method. As shown in Fig. 8A,
RNPs redistributed from intact virions at t-0 to a cytoplasmic
fraction between 10 and 20 minutes post-entry, similar to the time
when RNPs dissociated from MLG in Fig. 7. Likewise, M protein
redistributed to a fraction that was enriched in endosomal markers
beginning at 10 minutes and continuing until the end of the
Figure 3. Uncoating and distribution of M protein in live cells. Cells were inoculated with rVSV-MLG and Tfn-TR at 4uC for 90 minutes and
either fixed immediately with ice-cold 3% paraformaldehyde (t-0) or were quickly warmed by the addition of 37uC media and examined without
fixation by LSCM on a heated stage at the indicated times using separate 35mm glass bottomed dishes for each time point to reduce signal loss by
photobleaching. Bars = 10 mm. Arrowheads indicate MLG localization to NPCs.
doi:10.1371/journal.ppat.1000994.g003
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protein correlated well when using either confocal microscopy or a
cell fractionation assay.
To determine if RNP separation required microtubules rVSV-
MLG was endocytosed in the presence of NH4Cl for 1 hour and
then nocodazole and cycloheximide were added for 30 minutes to
depolymerize microtubules and stop protein synthesis. The cells
were either fixed immediately (Fig. 9A) or were incubated in the
presence of both inhibitors, or with nocodazole only, for an
additional 2 hours. Quantification of MLG and N protein
colocalization showed that at t-0, 92.8% (+/23.4%, n = 50
cells) of RNPs colocalized with MLG, whereas by t-120 (Fig. 9B)
most of the nucleocapsids had separated from M protein as
indicated by only 31.3% (+/28.2%, n = 50 cells) of RNP-MLG
colocalization. Similar to that observed in Figs. 3, 4 and 5, there
was very distinct MLG fluorescence associated with the nuclear
envelope at t-120, but importantly there was no N protein staining
of the nuclear membrane. This indicates that M protein localizes
to the nuclear envelope alone and not in association with RNPs.
As previously reported by others [28], we also observed that VSV
transcription and viral protein synthesis can occur following
infection of cells that lack an organized microtubule network
(Fig. 9C), as indicated by the extensive N protein staining
throughout the cytoplasm which represents new N protein
synthesis. These results also confirm that the N protein staining
seen in Fig. 9B represents incoming RNPs, and is not from new N
protein synthesis.
Spatial distribution of membrane bound-MLG during VSV
uncoating
When fusion between the virus and endosomal membranes
occurs, an asymmetry in the endosomal membrane is generated by
addition of the viral membrane to the endosomal membrane at the
site of membrane fusion. Based on the tight association of MLG
with the viral membrane it should be possible to visualize the
virus-endosome fusion event using MLG as a marker.
Figure 4. Localization of MLG at the nuclear envelope. (A) BHK cells were pre-treated with bafilomycin A1 (Baf) and then rVSV-MLG and Tfn-TR
were bound to cells in the cold in media containing Baf for 90 minutes. The inoculum was removed and the cells were incubated for 150 minutes at
37uC in media containing Baf. Cells were imaged by LSCM as described in Fig. 3. Bars = 10 mm. (B) Cells were infected with rVSV-MLG in the presence
of NH4Cl for 90 minutes to allow accumulation of virus in endosomes and then entry was initiated by incubation in media without NH4Cl, but
containing cycloheximide to prevent new viral protein synthesis. Cells were fixed at t-0 (top panels) and t-60 (bottom panels), stained for M protein
using a rhodamine conjugated anti-M mAb (red) and a Nup62 antibody labeled with Alexa Fluor-647 (blue), and examined by LSCM. White arrows
indicate the localization of MLG at the nuclear envelope. Note the M mAb does not detect M protein localized to the nuclear envelope (middle
panels, yellow arrows). Bars = 2 mm.
doi:10.1371/journal.ppat.1000994.g004
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entry and uncoating we analyzed high magnification confocal
images of endosomes from an experiment similar to that
described in Fig. 3. For this analysis we used a 100X-1.4 N.A.
apochromat objective and digitally magnified the image 56
prior to capture using 102461024 pixel resolution. Figure 10A
shows an example of an image collected 15 minutes post-entry
which clearly shows an asymmetric distribution of MLG
relative to Tfn-TR within an endosome. To determine if this
asymmetry required membrane fusion we produced MLG
virus particles lacking G protein (DG - M L G ) .W eh a v es h o w n
previously that ‘‘bald’’ DG-VSV is able to bind and enter cells,
albeit somewhat less efficiently than wt-VSV, and that the
virus is non-infectious due to the lack of G protein [29]. In
contrast to infectious rVSV-MLG, we found that MLG from
DG-MLG particles did not acquire an asymmetrical distribu-
tion (Fig. 10B), presumably because the particle remained
within the lumen of the endosome. As might be expected,
we also did not observe MLG from DG-MLG particles
associating with the nuclear envelope at any time point (data
not shown).
In addition to observing MLG at the site of membrane
fusion, we followed the fate of MLG post-fusion. We found that
by 20 to 30 minutes post-entry the asymmetry began to
Figure 5. Distribution of MLG in the presence of cytochalasin D or nocodazole. BHK cells were infected with rVSV-MLG in the presence of
NH4Cl as described for Fig. 4B. Cytoskeletal inhibitors were added for 30 minutes before NH4Cl washout and the inhibitors remained in the post-
washout media until the cells were fixed 60 minutes later. Distribution of MLG, Nup62 and actin (A) or tubulin (B) either without (top panels) or with
(bottom panels) cytoskeletal inhibitors. Arrows indicate nuclear envelope localization. The brightness levels were adjusted for all the images using
Canvas 11 software to maximize the MLG signal after conversion to grayscale. Bars = 10 mm.
doi:10.1371/journal.ppat.1000994.g005
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increased, reaching a plateau after approximately 60 minutes
(Fig. 10C and D). These data suggest that after binding of virus
to cells on ice, virus-endosome fusion occurs between 10 and
15 minutes after warming cells to 37uC. The data also suggest
that as M protein is exposed to the cytoplasm following
membrane fusion it begins to diffuse across the endosomal
membrane where it becomes evenly distributed as the lipids of
the viral and endosomal membranes continue to mix. The
kinetics of the increase in MLG surface area correlated with
Figure 6. Colocalization of MLG with markers for recycling endosomes. A synchronized fusion assay was performed as described for Fig. 4B,
the cells were fixed at t-60, stained for (A) LAMP-1, (B) mannose-6-phosphate receptor, (C) Tfn-TR, or (D) Rab11 and then examined by LSCM (Bars =
10 mm). Percent colocalization of MLG with the indicated marker from approximately 20 individual cells from two independent experiments is shown
in the upper right-hand corner of the merged images.
doi:10.1371/journal.ppat.1000994.g006
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initial low pH-induced decrease in MLG fluorescence, there
was a steady increase in fluorescence up to approximately
60 minutes post-entry. Based on the results shown in Fig. 10D,
the increase in fluorescence likely represents reduced packing
of MLG as it transitions from the ordered helical lattice found
within virions [9], to a more diffuse form found after uncoating
has occurred. This change in fluorescence and movement of
MLG across the endosomal membrane also correlates tempo-
rally with the reduction in colocalization of RNPs with MLG,
which represents the release of RNPs into the cytoplasm seen
in Fig. 7.
Discussion
To study VSV entry we generated rVSVs encoding fluores-
cently tagged M proteins (rVSV-MLG) using Lumio technology
and recently reported that very soon after initiation of rVSV-MLG
entry there is a transient decrease in MLG fluorescence, which we
suggested is due to acidification of the virion interior [19]. Between
5 and 10 minutes post-entry MLG fluorescence recovers to input
levels, which is followed by a steady increase in fluorescence that
plateaus between 60 and 150 minutes post-entry. In this report we
extend these studies by examining the intracellular distribution of
M protein during and after VSV uncoating and show that the bulk
Figure 7. Kinetics of RNP separation from MLG-endosomes. (A) rVSV-MLG was bound to cells in the cold as described for Fig. 3 except Tfn-TR
was omitted. Cells were fixed at the times indicated, permeabilized and RNPs were detected by staining for N protein using an N mAb conjugated to
Alexa Fluor-568. Images were collected by LSCM using identical detector, offset, and gain settings. Bars = 10 mm. (B) Colocalization of RNPs with MLG
from the images in (A) as a function of time post-entry. Significance was determined using Student’s t-test (n = 9 cells). (C) The red and green
channel levels for the t-5 and t-60 images from (A) were adjusted in Adobe Photoshop to give similar red and green intensities, which shows better
the colocalization of RNPs with MLG detected by the LSM software for the t-5 time point.
doi:10.1371/journal.ppat.1000994.g007
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released into the cytosol. We confirmed previous reports by others
[4,5], that VSV infection requires Rab5, but not Rab7, and
extended these studies by showing that DN-Rab11 also did not
inhibit VSV infection (Fig. 1). Our studies also provide the first
kinetic description of VSV uncoating with respect to the release of
RNPs following membrane fusion and the spatial relationship of
M protein and RNPs during the uncoating process.
Finding 1: M remains associated with endosomes after
uncoating
An important new finding from these studies was that most of
the incoming M protein remained associated with an endosomal
membrane at both early and at late times after entry. This was
seen both in cells that had virus bound to the cell surface in the
cold, as well as in cells where virus fusion was synchronized by
NH4Cl washout. By quantifying the amount of N protein that had
separated from MLG endosomes (Fig. 7), it appears that greater
than 75% of the virus had fused, therefore only a small fraction
represents unfused virus. Thus, most of the incoming virus enters
cells in a productive manner and the bulk of M protein remains
bound to the endosomal membrane. The topology of the viral
membrane after fusion would predict that the endosomal-
associated M would be exposed to the cytoplasm; therefore the
binding of M to the endosomal membrane must be quite strong.
Finding 2: M trafficking to NPCs
As the infection progressed, e.g. 60 to 150 minutes post-entry,
M protein was observed in large perinuclear structures, which
stained for markers of recycling endosomes. Following uncoating a
smaller proportion of M was apparently released and rapidly
localized to the nuclear envelope. These observations correlate
nicely with an earlier study which showed using a biochemical
assay that ,15% of input M was released into the cytosol after
entry [10]; however, in that study the distinct nuclear envelope
localization was not observed. Our results support the finding that
only a fraction of the incoming M protein is released in a soluble
form after uncoating. However, this small amount of M
colocalized with Nup62, suggesting that this soluble fraction binds
to nuclear pore complexes (NPCs). These data are consistent with
reports that GFP-M fusion proteins can associate with NPCs [27].
Based on our finding that M protein from incoming virus particles
also binds to NPCs, we propose that upon VSV entry, a small
amount of M protein is released after uncoating and that this
fraction associates with NPCs where it may block nucleocytoplas-
mic transport [30], thus representing an early effort by the virus to
mute the innate immune response even before viral protein
synthesis has begun.
The mechanism by which M is trafficked to the NPCs is less
clear. We observed localization of MLG on the nuclear envelope
in the absence of polymerized actin (Fig. 5A) or tubulin (Fig. 5B).
This was unexpected since early studies indicated that M protein
binds to the cytoskeleton [31,32] and it was assumed that M
trafficking to the nuclear envelope involves microfilaments or
microtubules. Alternatively, trafficking of M to the NPC may
involve M binding to RaeI. It is known that binding of M to RaeI
results in inhibition of mRNA nucleo-cytoplasmic transport and
that RaeI binds to microtubules in mitotic spindle complexes
[33,34]. Therefore, M could bind to RaeI in the cytoplasm and be
delivered to the NPCs; however, we observed M trafficking to the
nuclear envelope in the presence of nocodazole, suggesting that
localization to the NPC likely occurs by a different mechanism.
Our results also shed new light on the mechanism of VSV entry
and uncoating. There are currently two models proposed for how
VSV nucleocapsids are delivered to the cytoplasm. Both models
begin with the well-accepted paradigm that VSV particles are
endocytosed via the clathrin-dependent pathway and are delivered
to early endosomes. In the traditional model of VSV entry, once
the pH of the early endosomal lumen becomes acidified to
,pH 6.3, G protein undergoes conformational changes which
induce fusion of the viral envelope with the endosomal membrane
and the RNP is exposed to the cytoplasm where primary
transcription occurs. This model has gained support through the
use of siRNAs to knock-down essential Rab proteins required for
maturation of early to late endosomes [5,21] and by use of specific
inhibitors and TIRF microscopy [4]. A second model was recently
proposed in which fusion occurs early, but RNPs are not released
immediately and instead are trafficked in multi-vesicular bodies to
late endosomes where a ‘‘back-fusion’’ event occurs which releases
Figure 8. Cell fractionation and analysis of the distribution of RNPs and M protein during virus entry. rVSV-wt was bound to cells in the
cold for 90 minutes in the presence of cycloheximide to prevent new protein synthesis, the inoculum was removed and the cells were washed and
then either removed from the dish immediately (t-0) or warmed to 37uC and then harvested for fractionation at the times indicated. Fractions were
subjected to immunoblot analysis using polyclonal anti-VSV sera. Relevant regions of the immunoblot are shown. NV (no virus) indicates cells that
were mock infected and harvested at t-0. Graphs below the blots show quantification of N or M protein in each fraction. (A) N protein detected in the
P16 (plasma membrane-associated virions) and NDG pellet (detergent-resistant nucleocapsids) fractions. Times post-entry are shown above the
immunoblot. VSV N is a lane containing purified virus. (B) M protein detected in the S16 (plasma membrane and mitochondrial membrane) and NDG
supernatant (endosomal and nuclear membrane) fraction. NV (no virus) mock infected cells. VSV M is the lane containing purified virus. (C) The four
fractions probed with antibodies to the indicated cellular markers.
doi:10.1371/journal.ppat.1000994.g008
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model (at least for the majority of particles) in which VSV virions
fuse early in the endocytic pathway and RNPs are released, with
the unexpected observation that a significant pool of M protein
remains associated with the endosomal membrane long after RNP
release has occurred.
Finding 3: RNPs are released from endosome-bound M
protein
The use of fluorescently labeled M and the direct visualization of
M distribution by confocal microscopy have allowed us to describe
for the first time the spatio-temporal relationship of viral proteins
during VSV uncoating (Fig. 11). The following events are proposed
based on these data. Within 2 to 5 minutes, virions are internalized
and between 5 and 10 minutes they are exposed to low pH, which
can be detected by the loss of MLG fluorescence within the virion
interior (Fig. 11, step A, [19]). It is well established that low pH also
causes conformational changes in G protein [35,36] which bring
about the membrane fusion event [37,38] required for VSV
infection (Fig. 11,step B).Duringentry we found that MLGbecame
asymmetrically distributed and localized to one side of the
endosomal membrane, which we propose occurs as the virus
membrane merges with the delimiting membrane of the endosome
where the RNP is released into the cytoplasm (Fig. 11, step C).
There was a sharp decrease in the colocalization of RNPs with
MLG between 15 and 20 minutes post-entry, but since our analysis
measured the physical separation of RNPs and MLG, these data
suggest that the initial uncoating event would occur prior to this
time. We also propose that interactions between the condensed
RNP with MLG on the viral membrane maintains MLG in an
Figure 9. Release of RNPs from endosomes and viral protein synthesis in the presence of nocodazole. Confocal images of cells
inoculated with rVSV-MLG at t-0 (A) and t-120 (B and C) post-NH4Cl washout in the presence of cycloheximide and nocodazole (B), or just nocodazole
(C), and stained for VSV N protein using N mAb conjugated to Alexa Fluor-568. Quantification of the amount of colocalization was determined for 50
individual cells using the colocalization function in the LSM software version 3.2. Percent of N protein that colocalized with MLG is indicated for t-0
and t-120 (n = 50 cells). Bars = 5 mm.
doi:10.1371/journal.ppat.1000994.g009
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MLG fluorescence and that after the release of RNPs into the
cytoplasm this organization is lost resulting in the diffusion of MLG
across the endosomal membrane and the concomitant increase in
MLG fluorescence which we observed beginning approximately
15 minutes post-entry (Fig. 11, step D). As a result of uncoating,
some M is released into the cytoplasm and associates with NPCs
(Fig. 11, step E). By generating rVSVs encoding M-Lumio with
otherviralproteinsfusedtored,yellow,orcyanfluorescentproteins,
or multiple Lumio-tagged viral proteins that are differentially
labeled with Lumio-Green and Lumio-Red, it should be possible to
gain further insight to the early events in VSV entry and the
mechanisms of VSV uncoating.
Materials and Methods
Lumio Green labeling of rVSV-ML
BHK-21 cells on 100 mm plates at ,95% confluency were
infected with rVSV-ML or G-complemented DG-ML for 1 hour
as described previously [19] and then at 4 hours post-infection
(hpi) the cells were washed twice with reduced-serum Opti-MEM I
(Invitrogen) and replaced with 10 ml of Opti-MEM I containing
200 nM Lumio Green (Invitrogen). The supernatant was collected
18 hpi and labeled virus was concentrated by centrifugation over a
20% sucrose cushion at 38,000 rpm in an SW41 swinging bucket
rotor (Beckman) for 45 minutes. The viral pellet was resuspended
on ice in 1 ml of 10% sucrose-TN buffer (10 mM Tris,
pH 7.4;150 mM NaCl) and the virus was stored at 280uC. Titers
were determined by standard plaque assay on BHK-21 cells and
protein concentration was determined by a BCA protein assay
(Pierce) according to the manufacturer’s directions. Fluorescence
for each virus preparation was determined as described [19].
Expression of wild-type and dominant negative Rab
proteins
BHK-21 or MDCK cells were transfected with plasmids
(generous gifts from Dr. Terry Dermody, Vanderbilt University)
expressing either wild-type (wt) or dominant-negative (DN) Rab
proteins using either Lipofectamine (Invitrogen) for BHK cells, or
Effectene (Qiagen) for MDCKs according to the manufacturers
instructions. The wt and DN-Rab5 (S34N; [39,40]), Rab7 (N125I;
[41]), or Rab11 (S25N; [42,43]) proteins were fused to eGFP in the
plasmid p-eGFP (Clontech). Eighteen hours post-transfection the
BHK-21 cells were infected with rVSV-wt (MOI=10) and the
MDCK cells were infected with A/Aichi/2/68 (H3N2) influenza
(influenza stocks were a kind gift from Dr. Charles Russell, St. Jude
Children’s Research Hospital) and fixed at 8 hr (VSV), or 15 hr
(influenza) post-infection. The cells were then stained for VSV N
Figure 10. Spatio-temporal distribution of MLG during virus entry and uncoating. A synchronized entry assay was performed as described
for Fig. 4B using either rVSV-MLG (A) or ‘‘bald’’ DG-MLG (B) and the cells were imaged 15 minutes after addition of 37uC media. A region having a
high concentration of endosomes was magnified to 5006using the ‘‘crop’’ function of the LSM software to show intracellular vesicles containing
MLG and Tfn-TR. Arrows indicate an asymmetric distribution of MLG within Tfn-TR positive endosomes in rVSV-MLG infected cells. Bars = 5 mm. (C)
MLG distribution 150 minutes post-entry. (D) The sizes of the MLG ‘‘patch’’ found on Tfn-TR endosomes (n = 30 endosomes) from a live cell
experiment similar to that shown in Fig. 3 were measured using the Profile function of the Zeiss LSM510 software, version 3.2 and plotted as a
function of time post-entry.
doi:10.1371/journal.ppat.1000994.g010
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antibody conjugated to biotin (generous gift from Dr. Richard
Webby, St. Jude Children’s Research Hospital). Fluorescence
micrographs were collected using a Zeiss Axioplan 2 microscope
equipped with an HR Axiocam camera and Axiovision software.
Percent inhibition was determined from approximately 90 to 150
cells in 10–20 individual fields by counting the total number of
Rab-positive (eGFP-positive) cells in a field that were also VSV N-
or influenza NP-positive using the formula [(12(virus-positive
cells/Rab-positive cells))*100].
Immunofluorescence (IF) staining and confocal
microscopy
rVSV-MLG infected cells were washed twice with phosphate-
buffered saline, pH 7.4 (PBS) and then fixed for 15 minutes with
3% paraformaldehyde (PFA) in PBS at room temperature. The fix
solution was removed and the cells washed twice with PBS
containing 10 mM glycine and 0.05% sodium azide (PBS-glycine),
and then permeabilized with 1% Triton X-100 in PBS-glycine at
ambient temperature for 1 minute. After permeabilization, the cells
were washed twice with PBS-glycine and then stained with the
following antibodies as indicated in the figure legends: a) M protein
using monoclonal antibody (mAb) 23H12 [24] conjugated to
rhodamine, b) VSV N protein using mAb 10G4 [24] conjugated to
rhodamine or after incubation with a secondary goat anti-mouse
antibody conjugated to Alexa Fluor-633, c) Nup62 using mAb
#610497 (BD Biosciences), d) mannose 6 phosphate receptor (M-6-
P-R) using mAb #MA1-066 (Affinity BioReagents), e) LAMP-1
using an anti-LAMP-1 mAb (Developmental Studies Hybridoma
Bank attheUniversityofIowa), f)EEA1usinga polyclonalantibody
(#2411, Cell Signaling Technology), g) Rab11 using a polyclonal
antibody (#71-5300, Zymed Laboratories), or h) microtubules
using anti-a tubulin mAb (#A-11126, Molecular Probes). The
unconjugated primary antibodies were detected with goat anti-
mouse, or goat anti-rabbit secondary antibody conjugated to
rhodamine (Jackson Research Laboratories), or for anti-Nup62,
goat anti-mouse labeled with Zenon IgG2b Alexa Fluor-647 (#A-
21242 Invitrogen; Molecular Probes). Phalloidin conjugated to
TexasRed-X(Invitrogen;Molecular Probes)wasusedtostain actin.
The distribution of the indicated proteins was examined using laser
scanning confocal microscopy (Zeiss LSM 510 and AIM software
version 3.2) with the multi-track setting and 488nm, 543nm, or
633nm laser excitation in 1 micron optical sections. Percent
colocalization of M and N protein was accomplished using the
Profile function of the Zeiss LSM Physiology software package by
counting thenumber ofN proteinpuncta that colocalized with M in
a total of 50 cells from three differentexperiments. Colocalization of
MLG with the endosomal markers was quantified by selecting
individual cells (n= 5) and using the colocalization function of the
LSM Physiology software. Colocalization of MLG with endosomal
markers was determined from a 1 micron optical slice near the
center plane of the cell. For colocalization analysis, the threshold
settings for both green and red pixels were set at 100.
Live-cell entry assay
BHK-21 cells plated onto 35 mm glass bottomed culture dishes
(MatTek Corporation) were washed twice with ice-cold Opti-
MEM I (Invitrogen) and then placed at 4uC for 15 minutes.
Lumio-labeled virus (MOI 50) and human transferrin conjugated
to Texas Red (50 mg) were adsorbed in 0.1 ml ice-cold Opti-MEM
I for 60 minutes with rocking every 15 minutes on ice. Surface
binding was examined by washing the cells 3 times with ice cold
PBS. The cells were placed on ice and washed once with ice-cold
100mM desferrioxamine in PBS for 5 minutes to chelate residual
iron. The cells were then washed once with ice-cold acid wash
buffer (100mM sodium acetate, 50mM NaCl, pH 5.5) for
5 minutes to release transferrin-TR from transferrin receptors on
the cell surface. After the acid washing the cells were washed 3
Figure 11. Time-line of VSV entry and uncoating events. A model for VSV entry and uncoating based on the spatio-temporal imaging analysis
of MLG and RNP from rVSV-MLG. Relevant figures from the analyses are shown in parentheses. Observed times of the events are shown in red-colored
font. In the model, virions attach to the cell surface, are endocytosed and trafficked to early endosomes in a Rab5-dependent manner where low pH
induces conformational changes G resulting in acidification of the virion interior (A) and subsequent fusion of the viral and endosomal membrane (B).
Acidification of the virion interior has an effect on the M protein to destabilize interactions between membrane-associated M (green circles with
orange borders) and the condensed RNP, which results in release of the RNP into the cytoplasm after membrane fusion (C). The bulk of M remains
associated with endosomes, but begins to diffuse across the endosomal membrane after RNP release (D). A smaller fraction of M is released into the
cytosol and reaches the NPCs in a microtubule and actin independent manner (E).
doi:10.1371/journal.ppat.1000994.g011
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at 37uC. For MLG trafficking without acid washing, the ice-cold
inoculum was replaced with Opti-MEM I warmed to 37uC and
the cells were incubated for the times indicated. MLG and Tfn-
TR were imaged in live (non-fixed) cells on a Zeiss LSM 510 laser
scanning confocal microscopy using a heated stage set to 37uC and
an objective heating collar using alternating 488nm and 543nm
laser excitation in multi-track mode. The images were collected
using identical detector gain and offset settings for each time point.
The non-entry time point (t-0) was examined following addition of
2 ml of ice-cold Opti-MEM I on a stage at ambient temperature.
To reduce problems of sample photobleaching, separate plates
were examined for each time point.
Cell fractionation assay
The fractionation protocol was essentially that described
previously by others [44], with the following modification for
infection with VSV. BHK-21 cells plated in 35 mm dishes were
washed twice with ice-cold Opti-MEM I (Invitrogen) and then
placed at 4uC for 10 minutes. rVSV-wt (MOI 50) was adsorbed in
0.3 ml ice-cold Opti-MEM I for 90 minutes with rocking every
15 minutes on ice. The inoculum was removed and cells were
washed twice with ice-cold Opti-MEM I and then twice with ice-
cold PBS. The cells were then either harvested immediately by
incubation with 1 ml ice-cold MES buffer (150 mM NaCl with
25 mM MES, pH 6.5) for approximately 10 minutes (until the
cells could be removed from the plate by pipetting), or were
incubated for the times indicated in Opti-MEM I at 37uC. After
incubation at 37uC the cells were quickly cooled by the addition of
ice-cold PBS and then incubation for 10 minutes in ice-cold MES
buffer after which the cell suspensions were transferred into a
1.5 ml microfuge tube on ice. All subsequent steps were performed
on ice and with a microcentrifuge cooled to 4uC. Cells were
disrupted using a 1 ml syringe fitted with a 25-gauge needle by
forcing the cell suspension rapidly through the needle 20 times.
Cell disruption was assessed via trypan blue staining, which
showed .95% of the cells were trypan blue permeable after the
treatment. The cell suspension was then centrifuged at 10006g for
10 minutes. The supernatant was transferred to a clean tube on ice
and the supernatant fraction was centrifuged again at 10006g,t o
remove residual pelletable material. The first 10006g pellet was
kept on ice. The supernatant was transferred to a new tube and
then spun at 16,0006g for 10 minutes. The pellet from the
16,0006g spin (P16) was washed once with ice-cold MES buffer,
repelleted and then resuspended in SDS-PAGE sample buffer.
The supernatant (S16) was precipitated with 10% trichloroacetic
acid (TCA) and the pellet resuspended in SDS-PAGE sample
buffer. The pellet from the initial 10006g spin was washed once
with ice-cold MES buffer, respun and then the pellet was
resuspended in NDG buffer (1% Nonidet-40; 0.5% deoxycholate;
10% glycerol; 137 mM NaCl and 20 mM Tris, pH 8.0). After
incubation on ice for 2 minutes the suspension was centrifuged at
16,0006g for 10 minutes. The pellet (NDG pellet) was washed
once in NDG buffer, repelleted and then resuspended in SDS-
PAGE sample buffer. The supernatant (NDG supt) was TCA
precipitated and suspended in SDS-PAGE sample buffer.
Fractions were electrophoresed on a 9% acrylamide gel containing
SDS, transferred to Immobilon membrane and processed for
immunoblot detection using the following antibodies with
detection using the Pierce Dura-West Detection Reagent as
described by the manufacturer. N and M proteins in the relevant
fractions were quantified using Image J after scanning films and
importing the images into Photoshop (Adobe) as .TIFFs.
Antibodies used were a) polyclonal anti-VSV (#4006-F; Whitt
lab), b) anti-Nup62 (mAb #610497; BD Biosciences), c) anti-EEA1
(polyclonal antibody #2411; Cell Signaling Technology), d) anti-
Rab11 (polyclonal antibody #71-5300; Zymed Laboratories), e)
anti-a tubulin (mAb #A-11126; Molecular Probes), and f) anti-
mitochondrial membrane protein OxPhos Complex-I 39 kDa (CI-
39; mAb #A21344; Molecular Probes).
Entry inhibition and synchronized fusion assays
To prevent the acidification of endosomes we used either the
proton ATPase inhibitor bafilomycin A1 as described previously
[19], or the lysosomotropic reagent NH4Cl. For NH4Cl treatment
used to synchronize fusion of virions with endosomal membranes,
BHK-21 cells were washed twice with PBS and then washed twice
with PBS containing 100mM NH4Cl. Virus inocula, either with or
without 50 mg of transferrin-TR, were adsorbed in serum-free
DMEM (SF-DMEM) containing 100mM NH4Cl for 60 or
90 minutes. After adsorption the cells were washed with PBS four
times to remove the NH4Cl and then either fixed immediately (t-0)
with 3% paraformaldehyde in PBS, pH 7.4, or after 60 minutes (t-
60) following the addition of 2 ml of SF-DMEM containing 10mg/
ml cycloheximide at 37uC. Synchronized fusion assays using the
cytoskeletal inhibitors cytochalasin D or nocodazole were
performed as described above except virus was adsorbed for
60 minutes in SF-DMEM with 100mM NH4Cl and the medium
was replaced with SF-DMEM containing 10mM of the cytoskeletal
inhibitor and 100mM NH4Cl for 30 minutes. The NH4Cl was
then washed out as described above except that the cytoskeletal
inhibitors remained for the time indicated and then the cells were
fixed with 3% PFA and prepared for IF.
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